Markets:

Overview

News

Currencies

International

Treasuries

Tarsus Pharmaceuticals, Inc. - Common Stock (NQ:TARS)

64.64 -0.75 (-1.14%)

Streaming Delayed Price Updated: 10:35 AM EST, Feb 12, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Tarsus Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 Next >

Top 5 Health Care Stocks That Could Sink Your Portfolio In Q2 ↗

May 09, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

May 09, 2024

Via Benzinga

TARS Stock Earnings: Tarsus Pharmaceuticals Beats EPS, Beats Revenue for Q1 2024 ↗

May 08, 2024

TARS stock results show that Tarsus Pharmaceuticals beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Via InvestorPlace

A Glimpse Into The Expert Outlook On Tarsus Pharmaceuticals Through 4 Analysts ↗

February 29, 2024

Via Benzinga

ICU Medical To Rally Around 28%? Here Are 10 Top Analyst Forecasts For Wednesday ↗

February 28, 2024

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Via Benzinga

Earnings Scheduled For February 27, 2024 ↗

February 27, 2024

Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on revenue of $100.49 million.

Via Benzinga

Tarsus Pharmaceuticals's Earnings: A Preview ↗

February 26, 2024

Via Benzinga

Tarsus Pharmaceuticals - Mixed Projections ↗

February 02, 2024

Tarsus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions.

Via Talk Markets

SoFi Technologies Posts Q4 Earnings, Joins Cardlytics, McGrath RentCorp And Other Big Stocks Moving Higher On Monday ↗

January 29, 2024

U.S. stocks traded mixed, with the Dow Jones trading slightly lower on Monday. Shares of SoFi Technologies, Inc. (NASDAQ: SOFI) rose sharply during Monday’s session after the company reported...

Via Benzinga

Topics Stocks

Tarsus Pharmaceuticals Stock Scores Relative Strength Rating Upgrade ↗

December 21, 2023

On Thursday, Tarsus Pharmaceuticals stock reached a key technical milestone, seeing its Relative Strength Rating jump to 91 from 84.

Via Investor's Business Daily

HC Wainwright & Co. Maintains Buy Rating for Tarsus Pharmaceuticals: Here's What You Need To Know ↗

November 10, 2023

Via Benzinga

Big Stocks Moving Higher On Friday: Synaptics Reports Q1 Beat; Joins Lyft, Hologic, Blink Charging ↗

November 10, 2023

U.S. stocks traded higher, with the Dow Jones gaining around 80 points on Friday. Shares of Synaptics Incorporated (NASDAQ: SYNA) rose sharply on Friday after the company reported better-than-expected...

Via Benzinga

Topics Stocks

Recap: Tarsus Pharmaceuticals Q3 Earnings ↗

November 09, 2023

Via Benzinga

Earnings Preview: Tarsus Pharmaceuticals ↗

November 08, 2023

Via Benzinga

Expert Ratings for Tarsus Pharmaceuticals ↗

September 11, 2023

Via Benzinga

Why Wynn Resorts Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

November 10, 2023

Shares of Wynn Resorts, Limited (NASDAQ: WYNN) fell sharply on Friday after the company reported third-quarter financial results.

Via Benzinga

What 6 Analyst Ratings Have To Say About Tarsus Pharmaceuticals ↗

August 14, 2023

Via Benzinga

HC Wainwright & Co. Maintains Buy Rating for Tarsus Pharmaceuticals: Here's What You Need To Know ↗

July 26, 2023

Via Benzinga

Earnings Scheduled For November 9, 2023 ↗

November 09, 2023

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnings at $0.30 per share on revenue of $265.00 million.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

August 01, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

July 31, 2023

Via Benzinga

Tarsus Pharma Shares Under Pressure: Analyst Says Concerns Over Adverse Event Profile Overblown ↗

July 25, 2023

The FDA approved Tarsus Pharmaceuticals Inc's (NASDAQ: TARS) Xdemvy (lotilaner ophthalmic solution) 0.25% for

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

July 25, 2023

Via Benzinga

Why Shares of Tarsus Pharmaceuticals Are Up Thursday ↗

July 20, 2023

The company's lead therapy is getting close to the finish line of FDA approval.

Via The Motley Fool

Johnson & Johnson, Zions Bancorporation, Heritage-Crystal Clean And Other Big Stocks Moving Higher On Thursday ↗

July 20, 2023

U.S. stocks traded mixed, with the Dow Jones gaining over 200 points on Thursday. Here are some big stocks recording gains in today’s session. Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) shares rose...

Via Benzinga

Why Alaska Air Group Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

July 25, 2023

Gainers Aurora Acquisition Corp. (NASDAQ: AURC) shares jumped 192% to $30.54.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 18, 2023 ↗

May 18, 2023

Via Benzinga

Why Infosys Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

July 20, 2023

Gainers PainReform Ltd. (NASDAQ: PRFX) jumped 45.5% to $10.34 after declining 8% on Wednesday. PaiReform recently regained compliance with Nasdaq continued listing requirements.

Via Benzinga

OKYO Pharma Management Takes Company Stock In Private Placement Instead Of Deferred Pay ↗

April 18, 2023

Drug development can be notoriously slow, and it can take some companies 10 years or more to pass through all the trials and tests required by the Food and Drug Administration (FDA).

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 18, 2023 ↗

July 18, 2023

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Tarsus Pharmaceuticals, Inc. - Common Stock (NQ:TARS)

Headline News about Tarsus Pharmaceuticals, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today